These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 10452318)

  • 1. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
    Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
    J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
    Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
    Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system.
    Weber WA; Neverve J; Sklarek J; Ziegler SI; Bartenstein P; King B; Treumann T; Enterrottacher A; Krapf M; Häussinger KE; Lichte H; Präuer HW; Thetter O; Schwaiger M
    Eur J Nucl Med; 1999 Apr; 26(4):388-95. PubMed ID: 10199945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
    Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
    Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers.
    Paul AK; Tatsumi M; Yutani K; Fujino K; Hashikawa K; Nishimura T
    Nucl Med Commun; 2002 Jan; 23(1):103-10. PubMed ID: 11748445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative FDG-PET for axillary metastases in patients with breast cancer.
    Chung A; Liou D; Karlan S; Waxman A; Fujimoto K; Hagiike M; Phillips EH
    Arch Surg; 2006 Aug; 141(8):783-8; discussion 788-9. PubMed ID: 16924086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
    Tatsumi M; Yutani K; Watanabe Y; Miyoshi S; Tomiyama N; Johkoh T; Kusuoka H; Nakamura H; Nishimura T
    J Nucl Med; 1999 Apr; 40(4):566-73. PubMed ID: 10210214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
    Delbeke D; Patton JA; Martin WH; Sandler MP
    J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
    Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
    Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.
    Zhang H; Tian M; Oriuchi N; Higuchi T; Tanada S; Endo K
    Br J Radiol; 2002 May; 75(893):409-16. PubMed ID: 12036833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis.
    Yutani K; Shiba E; Kusuoka H; Tatsumi M; Uehara T; Taguchi T; Takai SI; Nishimura T
    J Comput Assist Tomogr; 2000; 24(2):274-80. PubMed ID: 10752892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
    Stokkel MP; ten Broek FW; van Rijk PP
    Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
    Ahn JH; Son EJ; Kim JA; Youk JH; Kim EK; Kwak JY; Ryu YH; Jeong J
    Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
    Avril N; Menzel M; Dose J; Schelling M; Weber W; Jänicke F; Nathrath W; Schwaiger M
    J Nucl Med; 2001 Jan; 42(1):9-16. PubMed ID: 11197987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
    Pai M; Park CH; Suh JH; Koh JH
    Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT.
    Sasada S; Masumoto N; Kimura Y; Kajitani K; Emi A; Kadoya T; Okada M
    AJR Am J Roentgenol; 2019 Nov; 213(5):1129-1135. PubMed ID: 31339353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.